SHH and eye neoplasm: In this framework, our findings position LRP2 loss as a reproducible molecular feature of ocular tumors, motivating future functional studies to test whether restoring megalin-dependent nutrient/morphogen handling or restraining SHH-pathway activity could mitigate the proliferative advantage conferred by its absence.